Randomized-controlled trial to evaluate the efficacy of Lusutrombopag on EVL-AS therapy in thrombocytopenic patients
Not Applicable
Recruiting
- Conditions
- iver Cirrhosis,Esophageal varices
- Registration Number
- JPRN-UMIN000031505
- Lead Sponsor
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients were excluded if they had a history of hypersensitivity of lusutrombopag, or if they were pregnant, or they had a history of arterial or venous thrombosis with on-going risk factors for thrombosis, or had a severe liver damages (Child-Pugh score C), or had a severe renal dysfunction, or took anticoagulant or antiplatelet drug.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method